Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies

Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell death (RCD), also known as programmed cell death (PCD), has been widely reported to have numerous links to the progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Minru, Qin, Rui, Huang, Wei, Zhu, Hong-Ping, Peng, Fu, Han, Bo, Liu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006445/
https://www.ncbi.nlm.nih.gov/pubmed/35414025
http://dx.doi.org/10.1186/s13045-022-01260-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006445/
https://www.ncbi.nlm.nih.gov/pubmed/35414025
http://dx.doi.org/10.1186/s13045-022-01260-0

Ejemplares similares